In contrast, type I NKT cells failed to hinder tumor growth of CD1d-negative U87 cells in the intracranial injection model, suggesting that human type I NKT cells exert direct cytotoxicity against CD1d-expressing glioblastoma cells [99]. This evidence concerns the gene CD1D and neoplasm.